IPCA LABORATORIES LTD. - 524494 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Copy of Newspaper publication13-11-2023
13-11-2023
IPCA LABORATORIES LTD. - 524494 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Transcript of Q2 / H1 FY24 Earnings Call13-11-2023
IPCA LABORATORIES LTD. - 524494 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Loss of Share Certificate13-11-2023
IPCA LABORATORIES LTD. - 524494 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio Link for Investors / Analysts Call held on 10.11.202310-11-2023
Ipca Laboratories Results Earnings Call for Q2FY24
Conference Call with Ipca Laboratories Management and Analysts on Q2FY24 Performance and Outlook. Listen to the full earnings transcript.10-11-2023
Q2FY24 Quarterly Result Announced for Ipca Laboratories Ltd.
Pharmaceuticals company Ipca Laboratories announced Q2FY24 results: Standalone Net Total Income up 11% at Rs 1,698.81 crore. Consolidated Net Total Income up 27% at Rs 2,072.51 crore. Indian formulations income is up 10 % at Rs 844.99 crore. Exports Income is up 14 % at Rs 720.72 crore. Standalone EBITDA margin (before forex (gain)/loss, other income, and Unichem acquisition cost) at 20.86% in Q2FY24 as against 18.85% in Q2FY23. Consolidated EBITDA margin (before forex (gain)/loss, other income, and Unichem acquisition cost) at 17.64% in Q2FY24 as against 17% in Q2FY23. Standalone Net Profit at Rs 162.13 crore down 2%. Consolidated Net Profit at Rs 145.06 crore up 1%. The Board has declared an interim dividend of Rs 21- per share (200%). Result PDF10-11-2023
IPCA Labs Q2 Results: Net profit flat year-on-year at Rs 145 crore
IPCA Labs Q2 earnings: Revenue from operations came in at Rs 2,034 crore, up 27 percent from Rs 1,601 crore year-ago quarter, the company said.10-11-2023
IPCA LABORATORIES LTD. - 524494 - Corporate Action-Board approves Dividend
Board has approved Interim dividend of Rs. 2/- per equity share (200%)10-11-2023
IPCA LABORATORIES LTD. - 524494 - Standalone And Consolidated Results For The 2Nd Quarter And Half Year Ended 30Th September, 2023
Standalone and Consolidated Results for the 2nd quarter and half year ended 30th September, 202310-11-2023
IPCA LABORATORIES LTD. - 524494 - Board Meeting Outcome for Standalone And Consolidated Results For 2Nd Quarter And Half Year Ended 30Th September, 2023
Standalone and Consolidated Results for 2nd quarter and half year ended 30th September, 202310-11-2023